Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. Its products include genetic engineering vaccines and multivalent vaccines. The company also provides technical services. Pulike Biological Engineering was founded in 1995 and is headquartered in Luoyang, China.

Jiangsu Academy of Agricultural Sciences is a Chinese private company located in Nanjing, with subsidiaries in China, that engages in agriculture research and development.

Changsha Ruidokang Biotechnology Co., Ltd., established on 2016-09-29, Business scope includes biological products,R&D of cosmetics;Biotechnology Extension Services;Food Science and Technology Research Services;Agricultural projects and technology consulting services;Agricultural technology extension service;food sales(limited branch);Biological Products Sales(limited branch);Cosmetic production(limited branch);Retailing of cosmetics and hygiene products;Sales of laboratory equipment and ventilation systems;Biological product production(limited branch).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Qingdao Yebio Bioengineering Co. Ltd. is a Chinese private company located in Qingdao. The firm engages in research and development, production and distribution of veterinary bioproducts for animal disease prevention, diagnosis and treatment.

Wuhan Keqian Biology is involved in the research and development, production, and sale of veterinary biological products, as well as the provision of technical services for the prevention of animal epidemics. They offer products including a combination vaccine, a vaccine for poultry, a pet vaccine, and a diagnostic reagent.

Qingdao Greenman Biological Engineering Co., Ltd., established on 2004-12-17, Business scope includes wholesale,retail:Chemical products and raw materials(Does not contain dangerous goods and first-class precursor chemicals),primary agricultural products,Mechanical equipment and accessories,Pre-packaged food,Daily necessities,Biological product(In addition to vaccines),feed,Feed additives;Business Consulting(Free of trade secrets and intermediaries);Biotechnology research and development and technical consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Jiangxi Zhongcheng Pharmaceutical Group Co., Ltd., established on 2003-08-08, Business scope includes veterinary medicine,Raw materials for veterinary medicine,Raw materials of traditional Chinese medicine extraction,Plant extracts,Production and sales of pet medicine;Chinese herbal medicine planting,Chinese herbal medicine acquisition;Research and development of veterinary pharmaceutical products,Technical Services,technology transfer,technical consulting;pet supplies,animal health products,feed,Feed additives,Sales of additive premixed feed;Self-operated or agent import and export business of various commodities and technologies(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Guangdong Haida Animal Veterinary Research Institute Co., Ltd., part of Guangzhou Haihao Investment Co Ltd, is a company headquartered in Guangzhou, China. The firm manufactures and distributes agricultural products; provides agricultural technology research services; provides veterinary services.

Alios is discovering and developing novel therapeutic agents based on three platform technologies including: small molecule activators of innate immunity antiviral pathways (RNase L activation), phosphate protected nucleotide prodrug chemistry, and glycoprotein-engineering of interferons (Glycoferonâ). This complementary group of platform technologies has the potential to generate a number of distinct therapeutic products to treat a variety of serious viral infections such as chronic hepatitis B and C, HIV infection, and respiratory viruses (e.g. pandemic influenza) and emerging viral diseases (e.g. SARS).

Tianjin Ringpu Bio Technology they develop and produce bio- pharmaceutical products for veterinary medicines and vaccines. They are manufacturer and service provider of animal health products.

Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France.

Part of Zoetis, Inc., Rhone Merieux is a company headquartered in France that manufactures pharmaceuticals, speciality and agricultural chemicals.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Hunan Zhongan Bio-Pharmaceutical Co., Ltd. (doing business as Zhongan Bio-Pharmaceutical Co. Ltd.), part of Tianjin Ringpu Bio-technology Co., Ltd., is a Chinese company located in Changsha that produces bacterial vaccine. It was acquired by Tianjin Ringpu Bio-technology Co., Ltd. from Hunan Yatai Biological Development Co., Ltd. on May 06, 2011 for $2.58 million.

Ningxia Tairui Pharmaceutical Co. Ltd. manufacture pharmacies and drug for animals. The firm engages in research and development, production and tiamulin fumarate. The company was founded on January 21, 2000 and is headquartered in Yinchuan, China.

Tianjin Zhongao Feed Sales Co., Ltd., established on 2003-02-13, Business scope includes feed wholesale and retail.(If the country has special regulations on monopoly within the above scope, it shall be handled according to the regulations)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.